Assessing Carotid RevascularizationShould We Abandon the Neurological Examination?*
Jay S. Yadav, MD, FACC*
Piedmont Heart Institute, Piedmont Hospital, Atlanta, Georgia
Key Words: carotid stenting MRI emboli stroke
Carotid stenting has become the treatment of choice in patients who need carotid endarterectomy (CEA) but are at high surgical risk (1,2). Concern remains about the incidence of stroke, particularly in the community hospital setting and in certain patient groups, particularly the elderly and symptomatic patients (3). Clearly, there is a need to make carotid revascularization, be it endarterectomy or stenting, safer. A blood test for stroke that is analogous to troponin or creatine phosphokinase-myocardial band for the heart would be ideal; the blood-brain barrier has posed a significant challenge and as yet none of these tests has been found acceptable (4,5).
In this issue of JACC: Cardiovascular Interventions, Schofer et al. (6) report on the use of serial diffusion weighted (DW) magnetic resonance imaging (MRI) as a surrogate marker for brain ischemia during carotid stenting. They are to be congratulated on continuing their previous work in this important area (7). They studied 59, mostly asymptomatic (86%), consecutive patients undergoing protected carotid stenting and performed sequential DW MRI scans after the procedure. One type of emboli prevention device (Emboshield, Abbott Laboratories, Abbott Park, Illinois) and 1 type of stent (Acculink, Abbott Laboratories) were used in the vast majority of cases. Clopidogrel (75 mg/day) was given for 3 days prior to the procedure or alternatively 600 mg was given immediately before the procedure.
None of the patients suffered a stroke or transient ischemic attack. Twelve (20.3%) patients had lesions, all ipsilateral, on the initial diffusion weighted imaging (DWI) scan, and 10 patients had lesions on the second scans, with 7 of these patients having had normal initial scans. In total, 19 of 59 (32%) patients had a lesion on 1 of the MRI studies. Interestingly, of the abnormal delayed scans, 4 of the 10 lesions were in the contralateral hemisphere. The lesions were very small, mean 0.29 mm2 for the first scan and 0.37 mm2 for the second scan, and typically only 1 lesion was present in a patient.
This is 1 of the few studies to do sequential scans and provides valuable insights into the timing of brain ischemia. There are, however, some methodological concerns that affect the interpretation of these results. Clopidogrel dosing immediately prior to the procedure may not allow sufficient time for platelet inhibition and may lead to increased microembolization; at least 2 h are needed to obtain adequate platelet inhibition after a 600-mg loading dose (8). Their practice of not pre-dilating prior to stent placement may also contribute to increased embolization as the stent is forced through the lesion.
Interestingly, the filter used in this study has 1 of the largest pore sizes, 140 µm, and the stent used has 1 of the largest cell sizes, 11.48 mm2 (9). The pivotal study of the Acculink stent did not use this filter; it used the Accunet filter, which has a substantially smaller pore size (10). It may well be that combining the filter with the largest pore size with the stent with the largest cell size created a "perfect storm" leading to high rates of microembolization. It is important to think of carotid devices as systems, because the pivotal studies were all done with a single filter and a single stent; the results of these trials may not be reproducible if various devices are combined, particularly if the devices have similar shortcomings, which may lead to an amplification of that deficiency.
Diffusion weighted imaging (DWI) measures the apparent coefficient of distribution of water, which becomes reduced in minutes after the onset of ischemia. Diffusion weighted imaging is a measure of ischemia, not infarction. Most small lesions indicated by DWI are not present on repeat MRI scanning several weeks later. In a study of 105 carotid stenting patients, 22 (21%) of the patients demonstrated 64 new lesions at 24 h after the procedure and at 6 months, 62 had resolved (11). The 2 lesions that did not resolve were the only ones also visible on T2-weighted MRI. The assumption is that lesions indicated by DWI are due to microembolization, but in 1 study there was no correlation between the number of microembolic signals on transcranial doppler (TCD) and the number of lesions on DW MRI (12).
To help put the incidence of lesions indicated by DWI that were reported by Schofer et al. (6) in perspective, it is worthwhile to look at the incidence of lesions indicated by DWI in some other common procedures. Diagnostic cerebral angiography had a higher incidence (26%) of lesions indicated by DWI than neurointerventional procedures (18%); this was felt to be due to heparinization during the interventional procedures (13). Addition of heparin and the use of air filters dramatically reduced the number of lesions indicated by DWI (14). Carotid endarterectomy has been associated with lesions indicated by DWI in 4% to 34% of patients (15,16). Cardiac surgery is associated with DWI prevalence post-operatively in 31% to 47% of patients (17,18). Even coronary angiography is associated with lesions in 14% to 15% of patients and crossing the aortic valve increases the prevalence of lesions to 22% (19,20).
Diffusion weighted MRI appears to be a very sensitive tool for detecting even minor cerebral ischemia, but it correlates poorly with clinical events. There has been speculation that these clinically silent lesions may, however, result in cognitive deficits that require neuropsychological testing for detection. The CAVATAS (Carotid and Vertebral Transluminal Angioplasty Study) trial has been the only randomized study of CEA versus carotid angioplasty/stenting to perform neuropsychological testing in even a subset of patients (21). No difference was found between the CEA and angioplasty arms, even though emboli protection was not used during the carotid interventions.
The findings on DW MRI should not be disregarded, however, and can provide a very sensitive marker to help us further improve carotid stenting. Certainly, substantial improvements could be made in access devices and techniques. Similarly, although the current generation of filters is more operator friendly, it is clear from the results in the elderly and symptomatic patients that capture efficiency needs to improve. An additional filter during stent dilation may be a straightforward technique to dramatically improve capture efficiency during the critical portion of the procedure. Diffusion weighted MRI should be used as a research tool to increase our understanding of carotid intervention and other medical procedures, but it cannot replace clinical end points in randomized trials.
 |
Footnotes
|
|---|
Dr. Yadav has been a consultant to Cordis and Abbott. Dr. Yadav was a shareholder in Angioguard, Inc. at the time of its purchase by Johnson & Johnson in 1999. He receives recurring payments from Johnson & Johnson as a former shareholder of Angioguard, Inc. He does not own any shares of stock in Johnson & Johnson.
* Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology. 
* Reprint requests and correspondence: Dr. Jay S. Yadav, Piedmont Heart Institute, 387 Technology Circle NW, Suite 500, Atlanta, Georgia 30313 (Email: jyadav{at}cardiomems.com).
 |
REFERENCES
|
|---|
- Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-1501.[Abstract/Free Full Text]
- Gurm HS, Yadav JS, Fayad P, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients N Engl J Med 2008;358:1572-1579.[Abstract/Free Full Text]
- Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting Catheter Cardiovasc Interv 2007;69:341-348.[CrossRef][Web of Science][Medline]
- Godet G, Watremez C, Beaudeux JL, Meersschaert K, Koskas F, Coriat P. S-100beta protein levels do not correlate with stroke in patients undergoing carotid endarterectomy under general anesthesia J Cardiothorac Vasc Anesth 2001;15:25-28.[CrossRef][Web of Science][Medline]
- Rasmussen LS, Christiansen M, Johnsen J, Gronholdt ML, Moller JT. Subtle brain damage cannot be detected by measuring neuron-specific enolase and S-100beta protein after carotid endarterectomy J Cardiothorac Vasc Anesth 2000;14:166-170.[CrossRef][Web of Science][Medline]
- Schofer J, Arendt M, Tübler T, Sandstede J, Schlüter M. Late cerebral embolization after emboli-protected carotid artery stenting assessed by sequential diffusion-weighted magnetic resonance imaging J Am Coll Cardiol Intv 2008;1:571-577.[Abstract/Free Full Text]
- Schlüter M, Tübler T, Steffens JC, Mathey DG, Schofer J. Focal ischemia of the brain after neuroprotected carotid artery stenting J Am Coll Cardiol 2003;42:1007-1013.[Abstract/Free Full Text]
- Hochholzer W, Trenk D, Frundi D, et al. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention Circulation 2005;111:2560-2564.[Abstract/Free Full Text]
- Bosiers M, de Donato G, DeLoose K, et al. Does free cell area influence the outcome in carotid artery stenting? Eur J Vasc Endovasc Surg 2007;33:135-141.[CrossRef][Web of Science][Medline]
- Gray WA, Hopkins LN, Yadav S. Protected carotid stenting in high-surgical-risk patients: The ARCHeR results J Vasc Surg 2006;44:258-269.[CrossRef][Web of Science][Medline]
- Hauth EAM, Jansen C, Drescher R, et al. MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting Am J Neuroradiol 2005;26:2336-2341.[Abstract/Free Full Text]
- Pinero P, Gonzalez A, Mayol A, et al. Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study Am J Neuroradiol 2006;27:1338-1345.[Abstract/Free Full Text]
- Bendszus M, Koltzenburg M, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study Lancet 1999;354:1594-1597.[CrossRef][Web of Science][Medline]
- Bendszus M, Koltzenburg M, Bartsch AJ, et al. Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography: a prospective, randomized trial Circulation 2004;110:2210-2215.[Abstract/Free Full Text]
- Barth A, Remonda L, Lovblad KO, et al. Silent cerebral ischemia detected by diffusion-weighted MRI after carotid endarterectomy Stroke 2000;31:1824-1828.[Abstract/Free Full Text]
- Muller M, Reiche W, Langenscheidt P, et al. Ischemia after carotid endarterectomy: comparison between transcranial Doppler sonography and diffusion-weighted MR imaging Am J Neuroradiol 2000;21:47-54.[Abstract/Free Full Text]
- Restrepo L, Wityk RJ, Grega MA, et al. Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery Stroke 2002;33:2909-2915.[Abstract/Free Full Text]
- Knipp SC, Matatko N, Wilhelm H, et al. Evaluation of brain injury after coronary artery bypass grafting: a prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging Eur J Cardiothorac Surg 2004;25:791-800.[Abstract/Free Full Text]
- Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study Lancet 2003;361:1241-1246.[CrossRef][Web of Science][Medline]
- Busing KA, Schulte-Sasse C, Fluchter S, et al. Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization—prospective evaluation at diffusion-weighted MR imaging Radiology 2005;235:177-183.[Abstract/Free Full Text]
- CAVATAS Investigators Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Transluminal Angioplasty Study (CAVATAS): a randomized trial Lancet 2001;357:1729-1737.[CrossRef][Web of Science][Medline]
Related Article
-
Late Cerebral Embolization After Emboli-Protected Carotid Artery Stenting Assessed by Sequential Diffusion-Weighted Magnetic Resonance Imaging
- Joachim Schofer, Melanie Arendt, Thilo Tübler, Jörn Sandstede, and Michael Schlüter
J. Am. Coll. Cardiol. Intv. 2008 1: 571-577.
[Abstract]
[Full Text]
[PDF]
|